Veracyte, Inc. (VCYT): Gross Profit
$362.53M
Year ended 2025-12-31
$402.96M
Trailing 12 months to 2026-06-30
+27.3%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $362.53M | +21.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $298.14M | +29.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $229.68M | +30.7% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $175.68M | n/a | 2025-02-28, From 2022-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Veracyte, Inc. (VCYT) | 2025-12-31 | $362.53M | +21.6% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $273.20M | +0.5% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $130.88M | +22.1% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $208.46M | +157.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $633.01M | +40.9% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $15.78M | -41.2% |
| Exagen Inc. (XGN) | 2025-12-31 | $38.80M | +17.2% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $5.06M | -44.9% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $3.67B | +13.0% |
Compare VCYT, CSTL, FLGT, BLLN side by side · Screen every company in Services-Medical Laboratories ↗